Nutrien Gains 17% in the Past Month: What's Driving the Stock?

NTR's shares rallied 17.2% in a month, edging past the Fertilizers industry's 16.8% growth as strong fertilizer markets drive momentum.

Zacks Investment Research • Sep 11, 2026

Thermo Fisher, Wells Fargo, Nutrien And More On CNBC's ‘Final Trades'

On CNBC's “Halftime Report Final Trades,” Bryn Talkington, managing partner of Requisite Capital Management, picked Horizon Kinetics Inflation Beneficiaries ETF (NYSE:INFL).

Benzinga • Sep 10, 2026

Why Is Nutrien (NTR) Up 20.9% Since Last Earnings Report?

Nutrien (NTR) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Sep 4, 2026

Why You Should Retain Nutrien Stock in Your Portfolio Now

NTR benefits from strong potash and nitrogen demand, higher fertilizer prices and cost gains, while sulfur costs and volume constraints weigh on results.

Zacks Investment Research • Sep 2, 2026

Goldman Sachs Nasdaq-100 ETF, Nutrien And More: CNBC's ‘Final Trades'

On CNBC's “Halftime Report Final Trades,” Bryn Talkington, managing partner of Requisite Capital Management, said Goldman Sachs Nasdaq-100 Premium Income ETF (NASDAQ:GPIQ) has a 10.5% yield.

Benzinga • Sep 1, 2026

Top 3 Materials Stocks That Could Sink Your Portfolio This Month

As of Sept. 1, 2026, three stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Benzinga • Sep 1, 2026

Nutrien: Lowering To A Hold On Mixed Q2 (Rating Downgrade)

Nutrien is lowered to a Hold after a mixed Q2, as higher sales were accompanied by weaker profitability, lower fertilizer volumes, and higher sulfur costs. Long-term fertilizer demand remains tied to crop production, but that does not remove the cyclicality of Nutrien's earnings. Near-term uncertainty remains in nitrogen, phosphate, and Retail, while potash performed better and the lower end of 2026 potash volume guidance was raised.

Seeking Alpha • Aug 31, 2026

Nutrien's Q2 Earnings Lag, Revenues Beat Estimates on Higher Prices

NTR's Q2 sales topped estimates as potash gains and stronger benchmark prices helped offset lower volumes and higher sulfur costs.

Zacks Investment Research • Aug 11, 2026

Nutrien: The Market Misjudges The Structural Gas Arbitrage And The Looming Ag Cycle

Nutrien Ltd. remains a Buy as current market pricing ignores dual catalysts: global LNG disruption and a reversal in the agricultural cycle. NTR's North American nitrogen assets benefit from structurally cheap gas, ensuring elevated margins for 2–3 years amid global LNG capacity outages. Rising global food prices and pent-up fertilizer demand set the stage for a cyclical upturn in NTR's potash, phosphate, and retail segments.

Seeking Alpha • Aug 10, 2026

Nutrien Q2 Earnings Call Highlights

Nutrien NYSE: NTR reported second-quarter adjusted EBITDA of $2.4 billion and first-half adjusted EBITDA of $3.5 billion, up 6% from a year earlier, as record potash sales volumes, proprietary-product margin growth and operating execution supported results.

MarketBeat • Aug 8, 2026